KLK8 and neoplasm: Further testing of how Klk8 knockdown enabled Activin-A to reduce tumor growth will require prior identification of the cells mediating pro- and/or anti-tumor effects of Activin-A on immune infiltrates, and of activin-specific target genes to reliably quantify potential changes in signaling dynamics.